OWLLX | VSCIX | OWLLX / VSCIX | |
Total Expense Ratio | 0.95 | 0.04 | 2,375% |
Annual Report Gross Expense Ratio | 3.70 | 0.04 | 9,250% |
Fund Existence | 4 years | 28 years | - |
Gain YTD | -8.242 | -4.355 | 189% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.36M | 148B | 0% |
Annual Yield % from dividends | 0.50 | 1.49 | 34% |
Returns for 1 year | -0.64 | 5.22 | -12% |
Returns for 3 years | 17.98 | 31.38 | 57% |
Returns for 5 years | N/A | 63.40 | - |
Returns for 10 years | N/A | 93.42 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PAPTX | 10.90 | -0.03 | -0.27% |
PACE Alternative Strategies P2 | |||
MKLOX | 20.20 | -0.15 | -0.74% |
BlackRock Global Allocation K | |||
GOFFX | 49.04 | -0.48 | -0.97% |
Invesco Global Opportunities R5 | |||
EIHSX | 13.47 | -0.14 | -1.03% |
Eaton Vance Worldwide Health Sci I | |||
GFVUX | 15.32 | -0.20 | -1.29% |
Goldman Sachs Focused Value R6 |